Spots Global Cancer Trial Database for lobaplatin
Every month we try and update this database with for lobaplatin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Clinical Trial of Chemotherapy With Lobaplatin and 5-FU in Recurrent Local or Distant Advanced NPC. | NCT03210389 | Recurrent Nasop... | Lobaplatin | 18 Years - 70 Years | Sun Yat-sen University | |
| Lobaplation or Cisplatin in Adjuvant Chemotherapy for Esophageal Carcinoma | NCT03413436 | Esophageal Canc... | Lobaplatin Cisplatin | - | Henan Cancer Hospital | |
| Effectiveness and Toxicity of Gemcitabine/Lobaplatin Versus Gemcitabine/Cisplatin as Second-line Treatment in Metastatic Breast Cancer | NCT01483300 | Breast Cancer | lobaplatin cisplatin | 18 Years - 70 Years | Harbin Medical University | |
| Dose Escalation of Lobaplatin Concurrent With IMRT for the Treatment of NPC: A Phase I Clinical Trial | NCT03188497 | Acute Toxic Eff... Tumor Responses | Lobaplatin linear accelera... | 18 Years - 65 Years | Fifth Affiliated Hospital, Sun Yat-Sen University | |
| A Study of Docetaxel and Lobaplatin Versus Docetaxel and Carboplatin Combination Regimen in Patients With Platinum-sensitive (>6 Months) Relapsed Ovarian Cancer | NCT01851746 | Recurrent Ovari... | 18 Years - 70 Years | Wuhan University | ||
| A Study of Docetaxel and Lobaplatin Versus Docetaxel and Carboplatin Combination Regimen in Patients With Platinum-sensitive (>6 Months) Relapsed Ovarian Cancer | NCT01851746 | Recurrent Ovari... | 18 Years - 70 Years | Wuhan University | ||
| Comparative Study of Lobaplatin and Paclitaxel in Advanced Gastric Cancer Patients With D2 Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy | NCT04808466 | Gastric Cancer Chemotherapy Ef... Surgery Metastasis Survival | Paclitaxel Lobaplatin | 18 Years - 75 Years | Wuhan Union Hospital, China | |
| Dose Escalation of Lobaplatin Concurrent With IMRT for the Treatment of NPC: A Phase I Clinical Trial | NCT03188497 | Acute Toxic Eff... Tumor Responses | Lobaplatin linear accelera... | 18 Years - 65 Years | Fifth Affiliated Hospital, Sun Yat-Sen University | |
| Applicability of 3D-HDRA in Patients With Primary Liver Cancer: A Randomized Controlled Trial | NCT05701436 | Liver, Cancer o... | Oxaliplatin Doxorubicin Lobaplatin Cisplatin Oxaliplatin, Le... Lobaplatin, Ral... | 18 Years - 75 Years | Zhujiang Hospital | |
| Docetaxel and Loplatin Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Locally Advanced SCCHN | NCT03117257 | Locally Advance... | Lobaplatin Cisplatin | 18 Years - 70 Years | Guiyang Medical University | |
| Applicability of PDOX in Patients With Primary Liver Cancer: A Randomized Controlled Trial | NCT05766605 | Hepatocellular ... | Oxaliplatin Doxorubicin Lobaplatin Cisplatin Oxaliplatin, Le... Lobaplatin, Ral... | 18 Years - 75 Years | Zhujiang Hospital | |
| Ramucirumab Combined With Nab-paclitaxel, Lobaplatin, and S-1 in Neoadjuvant Transformation Therapy for Advanced Gastric Cancer | NCT06169410 | Advanced Gastri... | nab-paclitaxel,... nab-paclitaxel,... | 18 Years - 75 Years | Xijing Hospital | |
| Applicability of 3D-HDRA in Patients With Primary Liver Cancer: A Randomized Controlled Trial | NCT05701436 | Liver, Cancer o... | Oxaliplatin Doxorubicin Lobaplatin Cisplatin Oxaliplatin, Le... Lobaplatin, Ral... | 18 Years - 75 Years | Zhujiang Hospital | |
| Docetaxel and Loplatin Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Locally Advanced SCCHN | NCT03117257 | Locally Advance... | Lobaplatin Cisplatin | 18 Years - 70 Years | Guiyang Medical University | |
| Advanced First-line Treatment of Short-term Postoperative Progression of Head and Neck Squamous Cell Carcinoma | NCT06170697 | Head and Neck S... | Camrelizumab Cisplatin Carboplatin Lobaplatin Nedaplatin Radiotherapy | 18 Years - 70 Years | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | |
| A Study of Docetaxel and Lobaplatin Versus Docetaxel and Carboplatin Combination Regimen in Patients With Platinum-sensitive (>6 Months) Relapsed Ovarian Cancer | NCT01851746 | Recurrent Ovari... | 18 Years - 70 Years | Wuhan University | ||
| A Clinical Trial of Chemotherapy With Lobaplatin and 5-FU in Recurrent Local or Distant Advanced NPC. | NCT03210389 | Recurrent Nasop... | Lobaplatin | 18 Years - 70 Years | Sun Yat-sen University | |
| Clinical Analysis of HIPEC for T4 Colorectal Cancer After Surgery | NCT03221608 | Colorectal Neop... | Surgery and HIP... Surgery without... | 18 Years - 70 Years | Sixth Affiliated Hospital, Sun Yat-sen University | |
| Ramucirumab Combined With Nab-paclitaxel, Lobaplatin, and S-1 in Neoadjuvant Transformation Therapy for Advanced Gastric Cancer | NCT06169410 | Advanced Gastri... | nab-paclitaxel,... nab-paclitaxel,... | 18 Years - 75 Years | Xijing Hospital | |
| Lobaplation or Cisplatin in Adjuvant Chemotherapy for Esophageal Carcinoma | NCT03413436 | Esophageal Canc... | Lobaplatin Cisplatin | - | Henan Cancer Hospital | |
| A Multi-center, Randomized, Double-blind, Phase III Clinical Trial of Leucogen Versus Placebo on Leukocyte and Platelet Whole-course Management Assisted by PFLL Chemotherapy in the Treatment of Stage IV, Recurrent or Metastatic NPC | NCT05780294 | Nasopharyngeal ... Leucogen Chemotherapy Myelosuppressio... | 5-fu Lobaplatin Placebo leucogen | 18 Years - 60 Years | Sun Yat-sen University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
